The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Business
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
& Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Fri, August 19, 2022 | 05:12
Health & Science
Why Korea's COVID-19 vaccination rate is so low
Posted : 2021-04-01 16:37
Updated : 2021-04-02 09:44
Print Preview
Font Size Up
Font Size Down
An elderly citizen receives a shot of the Pfizer COVID-19 vaccine at a vaccination center in Dongjak District, Seoul, Thursday. Yonhap
An elderly citizen receives a shot of the Pfizer COVID-19 vaccine at a vaccination center in Dongjak District, Seoul, Thursday. Yonhap

By Jun Ji-hye

Korea is lagging behind some other countries in COVID-19 vaccinations apparently due to its failure to preemptively secure vaccines, in addition to the comparatively low competitiveness of domestic pharmaceutical companies in new medicine development.

According to the latest data collated by the University of Oxford-based Our World in Data, the government has administered vaccines to 1.66 percent of the Korean population as of March 30, a little over a month after the country's vaccination program began Feb. 26.

This ranked Korea 111th in the world with regard to the share of people having received at least one dose of a COVID-19 vaccine.

An elderly citizen receives a shot of the Pfizer COVID-19 vaccine at a vaccination center in Dongjak District, Seoul, Thursday. Yonhap
Israel, which began vaccinations Dec. 19, with its Prime Minister Benjamin Netanyahu receiving the Pfizer vaccine and becoming the first Israeli citizen to be inoculated, has a rate of 60.5 percent.

The vaccination rate in the United Kingdom, which was the first in the world to begin COVID-19 vaccinations Dec. 8, stood at 45.19 percent, while that of the United States was tallied at 28.72 percent.

Korea's rate was lower than those of many other Asian countries, such as Singapore with 16.12 percent and India with 3.91 percent.

The global average inoculation rate stood at 7.24 percent.

The government was originally planning to administer vaccines to 11.5 million people during the April-June period in a bid to speed up the program, but the prospects for this don't seem very hopeful, due to intensifying competition between countries to secure the vaccines amid supply shortages.

India, a major supplier of the AstraZeneca vaccine, has placed a temporary hold on all exports of the vaccine to meet domestic demand amid increasing infections there. This is posing setbacks to many other nations' programs, according to foreign news reports.

New COVID-19 cases above 500 for 2nd day; loosened vigilance hampering virus fight
New COVID-19 cases above 500 for 2nd day; loosened vigilance hampering virus fight
2021-04-01 09:46  |  Health & Science
Korea begins inoculating elderly aged 75 and older
Korea begins inoculating elderly aged 75 and older
2021-04-01 10:59  |  Health & Science

The European Union has also toughened rules on exports, requiring companies to seek authorization before exporting vaccines, as part of measures to check if companies are respecting their supply commitments with the EU.

Amid growing "vaccine nationalism" around the world, Korea, which failed to preemptively secure an adequate supply in the first place, is struggling to keep up with its initial plan.

Yang Dong-gyo, a government official in charge of the vaccination program, said Thursday that the country will receive AstraZeneca vaccines via the COVAX Facility, the World Health Organization-led global vaccine distribution project, this Saturday. But the amount has been reduced to shots for 216,000 people from for 345,000.

The delivery of vaccines, which had been originally scheduled to depart from the Netherlands on Wednesday, has been pushed back to the third week of April and then changed again to this Saturday, showing that the vaccine supply situation around the world is very unstable.

Adding to concerns is that the authorities here are failing to advise when additional AstraZeneca vaccines for 700,000 people as well as Johnson & Johnson's Janssen, Moderna and Novavax vaccines will arrive.

Experts said the ongoing problem was not a huge surprise, given that some developed countries have dominated the global vaccine market.

"This was why countries like Israel and Singapore, which have no relevant technologies, purchased vaccines at high prices, preemptively," said Kim Woo-joo, a professor of infectious diseases at Korea University.

Park In-sook, a professor emeritus at Asan Medical Center and a former lawmaker of the Saenuri Party, a predecessor of the main opposition People Power Party, also wrote on Facebook: "This is the worst-case scenario, about which health experts expressed concerns. It will be difficult for us to end the COVID-19 pandemic here within the year."

Questions have also been raised over why Korea has been unable to develop vaccines.

Song Si-young, a professor of Yonsei University College of Medicine, said this was not a surprise either, considering the low competitiveness of domestic pharmaceutical companies.

"Global pharmaceutical companies have made large profits following their development of vaccines in only about one to two years, whereas domestic firms have made no particular achievements since their announcement of the beginning of the clinical trials," he said.

"In general, it takes 10 to 15 years to develop new medicine, with less than a 1 percent probability of success. Global pharmaceutical companies could develop vaccines in about a year as they worked hard to conduct basic research for over 20 years."

He said more investment should made in the R&D sector by domestic drugmakers for the future of the industry here.




Emailjjh@koreatimes.co.kr Article ListMore articles by this reporter
 
LG
  • Korean businesses pressure gov't to lower inheritance tax
  • Suga of BTS remakes Galaxy's signature ringtone
  • Hit TV series leads to surge in visitors to southern region of Korea seeking glimpse of dolphins
  • Minister rebuked for 'submissive' stance toward Japan
  • Yoon to reshuffle presidential office to regain public trust
  • Shinsegae to open integrated shopping mall in Gwangju
  • Seoul to provide subsidies to households with babysitting grandparents
  • Government struggles to handle unused coronavirus vaccines
  • Household income grows at record pace amid soaring inflation
  • Will Inflation Reduction Act impact Hyundai, Kia's EV sales in US?
  • Interactive News
  • With tough love,
  • 'Santa dogs' help rebuild burnt forests in Andong
  • 'Santa dogs' help rebuild burnt forests in Andong
  • A tale of natural wine
    • [INTERVIEW] YouTubers bridge Korean, Muslim and Latin American cultures [INTERVIEW] YouTubers bridge Korean, Muslim and Latin American cultures
    • 'Mukbang' binge-eating shows give way to new trend of eating little 'Mukbang' binge-eating shows give way to new trend of eating little
    • [INTERVIEW] Jung Woo shapes his character for Netflix's 'A Model Family' [INTERVIEW] Jung Woo shapes his character for Netflix's 'A Model Family'
    • NCT Jaehyun drops first solo single 'Forever Only' NCT Jaehyun drops first solo single 'Forever Only'
    • Artist Do Ho Suh invites children to his clay fairyland Artist Do Ho Suh invites children to his clay fairyland
    DARKROOM
    • Ice is melting, land is burning

      Ice is melting, land is burning

    • Tottenham 6-3 Team K League

      Tottenham 6-3 Team K League

    • Afghanistan earthquake killed more than 1,000

      Afghanistan earthquake killed more than 1,000

    • Divided America reacts to overturn of Roe vs. Wade

      Divided America reacts to overturn of Roe vs. Wade

    • Namaste: Yogis to celebrate International Yoga Day

      Namaste: Yogis to celebrate International Yoga Day

    The Korea Times
    CEO & Publisher : Oh Young-jin
    Digital News Email : webmaster@koreatimes.co.kr
    Tel : 02-724-2114
    Online newspaper registration No : 서울,아52844
    Date of registration : 2020.02.05
    Masthead : The Korea Times
    Copyright © koreatimes.co.kr. All rights reserved.
    • About Us
    • Introduction
    • History
    • Location
    • Media Kit
    • Contact Us
    • Products & Service
    • Subscribe
    • E-paper
    • Mobile Service
    • RSS Service
    • Content Sales
    • Policy
    • Privacy Statement
    • Terms of Service
    • 고충처리인
    • Youth Protection Policy
    • Code of Ethics
    • Copyright Policy
    • Family Site
    • Hankook Ilbo
    • Dongwha Group